The resolution of inflammation is a protective response. The identification and characterization of new players that boost this response might inform the development of novel therapies for non-resolving inflammatory diseases.
References
Serhan, C. N. Nature 510, 92–101 (2014).
Kotas, M. E. & Medzhitov, R. Cell 160, 816–827 (2015).
Kourtzelis, I. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0249-1 (2019).
Buckley, C. D., Gilroy, D. W. & Serhan, C. N. Immunity 40, 315–327 (2014).
Perretti, M., Leroy, X., Bland, E. J. & Montero-Melendez, T. Trends Pharmacol. Sci. 36, 737–755 (2015).
Hanayama, R., Tanaka, M., Miwa, K. & Nagata, S. J. Immunol. 172, 3876–3882 (2004).
Choi, E. Y. et al. Science 322, 1101–1104 (2008).
Tabas, I. & Glass, C. K. Science 339, 166–172 (2013).
Van Dyke, T. E. & Serhan, C. N. J. Dent. Res. 82, 82–90 (2003).
Fredman, G. & Tabas, I. Am. J. Pathol. 187, 1211–1221 (2017).
Serhan, C. N., Chiang, N. & Dalli, J. Mol. Aspects Med. 64, 1–17 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Fredman, G. DELineating resolution of inflammation. Nat Immunol 20, 2–3 (2019). https://doi.org/10.1038/s41590-018-0278-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0278-9
- Springer Nature America, Inc.